Literature DB >> 19625383

Differential preferences in serosal homing and distribution of peritoneal B-cell subsets revealed by in situ CFSE labeling.

Arpád Lábadi1, Péter Balogh.   

Abstract

Peritoneal B cells represent a heterogeneous mixture of mature peripheral B lineage subsets with distinct developmental and functional characteristics. Here, we report that a single intraperitoneal injection of intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester (CFSE) results in the stable fluorescent labeling of resident lymphocytes, without dissipation of the tracer compound into other peripheral lymphoid organs. Using this in situ labeling procedure followed by multicolor flow cytometry or tissue fluorescence at various periods for up to 4 weeks post-labeling, we demonstrate that the distinct peritoneal leukocyte sub-populations and, within the B lineage, B-1 and B-2 B-cell subsets have different exchange kinetics with extraperitoneal sites under steady-state conditions. The B cells labeled with CFSE showed only minimal localization to other peripheral lymphoid tissues. On the other hand, a substantial fraction of both B-1 and B-2 subsets labeled with CFSE accumulated within the pleural cavity, although at a lower frequency than in the peritoneum. We also show that exposure to LPS induces a rapid re-distribution of peritoneal B lymphocytes and an enhanced entry of B-1 cells in the pleural cavity, in addition to augmenting the egress and the division-linked reduction of CFSE fluorescence of both B-1 and B-2 cells. These data indicate that following their in situ labeling, peritoneal lymphocytes show preferential accumulation in serosal cavities, although with a differential efficiencies for T, B-1 and B-2 lymphocyte subsets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625383     DOI: 10.1093/intimm/dxp071

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Antigen specific killing assay using CFSE labeled target cells.

Authors:  Marina Durward; Jerome Harms; Gary Splitter
Journal:  J Vis Exp       Date:  2010-11-09       Impact factor: 1.355

2.  A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.

Authors:  Ling-Hui Hsu; Kun-Po Li; Kuan-Hua Chu; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

Review 3.  New insights into heterogeneity of peritoneal B-1a cells.

Authors:  Hongsheng Wang; Jian-xin Lin; Peng Li; Jeff Skinner; Warren J Leonard; Herbert C Morse
Journal:  Ann N Y Acad Sci       Date:  2015-05-18       Impact factor: 5.691

4.  Intraperitoneal Glucose Transport to Micrometastasis: A Multimodal In Vivo Imaging Investigation in a Mouse Lymphoma Model.

Authors:  Zsombor Ritter; Katalin Zámbó; Xinkai Jia; Dávid Szöllősi; Dániel Dezső; Hussain Alizadeh; Ildikó Horváth; Nikolett Hegedűs; David Tuch; Kunal Vyas; Péter Balogh; Domokos Máthé; Erzsébet Schmidt
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

5.  B1a cells play a pathogenic role in the development of autoimmune arthritis.

Authors:  Jun Deng; Xiaohui Wang; Qian Chen; Xiaoxuan Sun; Fan Xiao; King-Hung Ko; Miaojia Zhang; Liwei Lu
Journal:  Oncotarget       Date:  2016-04-12

6.  Splenectomy modulates the immune response but does not prevent joint inflammation in a mouse model of RA.

Authors:  Esam Khanfar; Katalin Olasz; Erzsébet Gajdócsi; Xinkai Jia; Timea Berki; Péter Balogh; Ferenc Boldizsár
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

Review 7.  An Overview of B-1 Cells as Antigen-Presenting Cells.

Authors:  Ana F Popi; Ieda M Longo-Maugéri; Mario Mariano
Journal:  Front Immunol       Date:  2016-04-11       Impact factor: 7.561

8.  Ameliorated Autoimmune Arthritis and Impaired B Cell Receptor-Mediated Ca2+ Influx in Nkx2-3 Knock-out Mice.

Authors:  Esam Khanfar; Katalin Olasz; Fanni Gábris; Erzsébet Gajdócsi; Bálint Botz; Tamás Kiss; Réka Kugyelka; Tímea Berki; Péter Balogh; Ferenc Boldizsár
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.